Genuine Parts
GPC
125.41
-1.97
-1.55%
Genuine Parts
US · GPC
#1020 by market cap
Listed 1970
125.41
-1.97
-1.55%
Live - 5344 symbols - heartbeat 163s ago
· 2026-10-08 08:25
Pre-market
125.99
+0.46%
After-hours
125.41
0.00%
Overnight
125.50
+0.07%
- Market cap
- 17.29B
- P/E (TTM)i
- 501.64
- P/Bi
- 3.82
- EPSi
- 0.47
- Div yieldi
- 3.34%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on GPC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.35, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.46% YoY
Margins
- Gross margin
- 36.79%
- Operating margin
- 5.00%
- Net margin
- 0.27%
Key ratios & quality
- Enterprise valuei
- 21.61B
- Altman Z-Scorei
- 2.35
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.83B | 17.52B | 16.54B | 18.87B | 22.10B | 23.09B | 23.49B | 24.30B |
| Gross profit | 5.52B | 5.86B | 5.65B | 6.63B | 7.74B | 8.29B | 8.52B | 8.94B |
| Selling & admin expenses | 4.24B | 4.58B | 4.39B | 5.16B | 5.76B | 6.17B | 6.64B | 7.15B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.04B | 1.01B | 971.68M | 1.16B | 1.61B | 1.75B | 1.44B | 1.21B |
| Pretax profit | 994.64M | 859.28M | 379.37M | 1.20B | 1.57B | 1.74B | 1.18B | 52.17M |
| Tax | 245.10M | 212.81M | 215.97M | 301.56M | 389.90M | 425.82M | 271.89M | -13.78M |
| Net profit | 810.47M | 621.09M | -29.10M | 898.79M | 1.18B | 1.32B | 904.08M | 65.95M |
| Basic EPS | 6 | 4 | 0 | 6 | 8 | 9 | 6 | 0 |
| Diluted EPS | 5.50 | 4.24 | -0.20 | 6.23 | 8.31 | 9.33 | 6.47 | 0.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.87B | 6.16B | 6.26B | 6.01B | 6.26B | 6.54B |
| Gross profit | 2.17B | 2.32B | 2.34B | 2.10B | 2.34B | 2.47B |
| Selling & admin expenses | 1.71B | 1.77B | 1.81B | 1.86B | 1.86B | 1.92B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 342.72M | 422.55M | 401.13M | 48.22M | 344.00M | 407.49M |
| Pretax profit | 251.64M | 338.56M | 291.69M | -829.72M | 245.39M | 293.83M |
| Tax | 57.25M | 83.68M | 65.52M | -220.22M | 56.86M | 66.27M |
| Net profit | 194.39M | 254.88M | 226.17M | -609.50M | 188.54M | 227.56M |
| Basic EPS | 1 | 2 | 2 | -4 | 1 | 2 |
| Diluted EPS | 1.40 | 1.83 | 1.62 | -4.39 | 1.37 | 1.65 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.58B | 7.94B | 7.11B | 7.76B | 8.82B | 9.61B | 9.85B | 10.56B |
| Cash & ST investments | 333.55M | 276.99M | 990.17M | 714.70M | 653.46M | 1.10B | 479.99M | 477.18M |
| Inventory | 3.61B | 3.44B | 3.51B | 3.89B | 4.44B | 4.68B | 5.51B | 6.07B |
| Total assets | 12.68B | 14.65B | 13.44B | 14.35B | 16.50B | 17.97B | 19.28B | 20.80B |
| Total current liabilities | 5.90B | 6.39B | 5.89B | 6.58B | 7.69B | 7.83B | 8.53B | 9.79B |
| Short-term debt | 711.15M | 624.04M | 160.53M | -- | 252.03M | 355.30M | 541.71M | 1.30B |
| Long-term debt | 2.43B | 2.80B | 2.52B | 2.41B | 3.08B | 3.55B | 3.74B | 3.50B |
| Total liabilities | 9,211,049,000.00 | 10,950,129,000.00 | 10,222,212,000.00 | 10,848,812,000.00 | 12,690,932,000.00 | 13,551,469,000.00 | 14,930,854,000.00 | 16,355,177,000.00 |
| Total equity | 3.47B | 3.70B | 3.22B | 3.50B | 3.80B | 4.42B | 4.35B | 4.44B |
| Retained earnings | 4.34B | 4.57B | 3.98B | 4.09B | 4.54B | 5.07B | 5.26B | 4.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 10.21B | 10.47B | 10.67B | 10.56B | 10.88B | 11.07B |
| Cash & ST investments | 420.45M | 457.99M | 431.36M | 477.18M | 500.02M | 559.12M |
| Inventory | 5.63B | 5.77B | 5.87B | 6.07B | 6.13B | 6.29B |
| Total assets | 19.82B | 20.43B | 20.69B | 20.80B | 20.98B | 21.06B |
| Total current liabilities | 8.89B | 9.21B | 9.38B | 9.79B | 9.96B | 9.55B |
| Short-term debt | 813.94M | 1.06B | 1.01B | 1.30B | 1.52B | 1.00B |
| Long-term debt | 3.78B | 3.74B | 3.75B | 3.50B | 3.48B | 3.98B |
| Total liabilities | 15,352,642,000.00 | 15,712,149,000.00 | 15,889,741,000.00 | 16,355,177,000.00 | 16,484,360,000.00 | 16,514,504,000.00 |
| Total equity | 4.46B | 4.72B | 4.81B | 4.44B | 4.49B | 4.54B |
| Retained earnings | 5.32B | 5.43B | 5.51B | 4.57B | 4.61B | 4.69B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.15B | 892.01M | 2.02B | 1.26B | 1.47B | 1.44B | 1.25B | 890.76M |
| Depreciation & amortization | 227.58M | 257.26M | 272.84M | 290.97M | 347.82M | 350.53M | 407.98M | 538.02M |
| Free cash flow | 918.66M | 614.14M | 1.87B | 992.15M | 1.13B | 922.94M | 683.91M | 420.92M |
| Dividends paid | -415.98M | -438.89M | -453.28M | -465.65M | -495.92M | -526.67M | -554.93M | -563.84M |
| Stock buybacks / issuance | -91.98M | -74.19M | -96.22M | -333.60M | -222.73M | -261.47M | -150.00M | 0 |
| Ending cash balance | 333.55M | 276.99M | 990.17M | 714.70M | 653.46M | 1.10B | 479.99M | 477.18M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -40.83M | 209.94M | 341.57M | 380.07M | 63.92M | 400.20M |
| Depreciation & amortization | 115.44M | 123.02M | 127.48M | 172.10M | 131.03M | 134.72M |
| Free cash flow | -160.67M | 80.96M | 239.95M | 260.68M | -33.64M | 292.36M |
| Dividends paid | -134.36M | -142.95M | -143.27M | -143.27M | -141.75M | -146.23M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 420.45M | 457.99M | 431.36M | 477.18M | 500.02M | 559.12M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.62 | 17.43 | -0.85 | 26.85 | 32.49 | 32.14 | 20.69 | 1.51 |
| ROA %i | 6.46 | 4.55 | -0.21 | 6.47 | 7.67 | 7.64 | 4.85 | 0.33 |
| ROIC %i | 13.34 | 9.54 | 0.54 | 14.32 | 16.62 | 15.84 | 10.11 | 1.85 |
| 5-year avg ROE %i | 21.45 | 20.66 | 16.11 | 17.15 | 19.91 | 21.61 | 22.26 | 22.74 |
| EBIT margin %i | 6.29 | 4.78 | 2.86 | 6.69 | 7.45 | 7.82 | 5.42 | 0.89 |
| FCF / sales %i | 4.87 | 3.06 | 11.28 | 5.26 | 5.10 | 4.00 | 2.91 | 1.73 |
| Current ratioi | 1.28 | 1.24 | 1.21 | 1.18 | 1.15 | 1.23 | 1.16 | 1.08 |
| Quick ratioi | 0.48 | 0.42 | 0.43 | 0.38 | 0.37 | 0.42 | 0.43 | 0.38 |
| Debt / assetsi | 24.78 | 28.56 | 25.79 | 22.29 | 25.25 | 27.19 | 29.78 | 31.43 |
| LT debt / equityi | 70.49 | 96.84 | 103.16 | 91.63 | 103.23 | 102.95 | 119.91 | 118.42 |
| Interest coveragei | 11.55 | 9.68 | 5.05 | 20.31 | 22.28 | 28.03 | 13.15 | 1.32 |
| Revenue CAGR (3Y) %i | 3.28 | 4.53 | 0.47 | 3.89 | 8.04 | 11.77 | 7.57 | 3.22 |
| Net income CAGR (3Y) %i | 4.72 | -3.32 | -- | 3.51 | 23.95 | -- | 0.20 | -61.80 |
| FCF CAGR (3Y) %i | -4.35 | -7.87 | 41.53 | 2.60 | 22.44 | -20.92 | -11.66 | -27.99 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.19 | 17.50 | 17.05 | 1.51 | 1.35 | 0.71 |
| ROA %i | 4.45 | 4.12 | 3.95 | 0.33 | 0.29 | 0.16 |
| ROIC %i | 9.44 | 8.74 | 8.43 | 1.85 | 1.49 | 1.24 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.17 | 5.00 | 4.97 | 0.89 | 0.88 | 0.71 |
| FCF / sales %i | 1.36 | 1.06 | 0.55 | 1.73 | 2.22 | 3.03 |
| Current ratioi | 1.15 | 1.14 | 1.14 | 1.08 | 1.09 | 1.16 |
| Quick ratioi | 0.44 | 0.44 | 0.44 | 0.38 | 0.39 | 0.42 |
| Debt / assetsi | 30.79 | 31.43 | 30.92 | 31.43 | 32.01 | 31.59 |
| LT debt / equityi | 118.84 | 113.95 | 112.52 | 118.42 | 116.12 | 124.84 |
| Interest coveragei | 10.47 | 8.83 | 8.13 | 1.32 | 1.27 | 1.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- North America Automotive Segment is the largest reported line at 38.81% of revenue, across 3 reported segments.
- No single line clears half of revenue; Industrial Segment is next at 36.89%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
North America Automotive Segment38.81%
Industrial Segment36.89%
International Automotive Segment24.29%
Quote time 2026-10-08 08:25:51 · For reference only, not investment advice and not tailored to your situation.